Toll Free Helpline (India): 1800 1234 070

Rest of World: +91-9810852116

NAAS RATING: 5.23, Impact Factor: RJIF 5.98 | Free Publication Certificate
updates
NAAS Rating: 5.23 new

Vol. 8, Issue 1 (2019)

Resveratrol protects acrylamide / glycidamide induced genotoxicity in hepatic cell line

Author(s):
A Ranjini and HK Manonmani
Abstract:
Resveratrol has been regarded to exhibit antigenotoxic effects. Resveratrol was isolated from healthy grape berries and wine. The trans-resveratrol was purified, characterized by HPLC and LC-MS. In this study the protective effect of trans-resveratrol against genotoxicity induced by acrylamide (AA), a toxicant formed in carbohydrate-rich foods subjected to temperatures, above 140º C and its metabolite glycidamide (GA) resulting from cytochrome P450 2E1 (CYP2E1) was investigated in HepG2 cells. Pretreatment of HepG2 cells with resveratrol (RES) showed ameliorating effects on AA and GA induced cytotoxicity, decreased the reactive oxygen species (ROS), and prevented DNA damage, micronucleus induction. Also resveratrol exhibited decreased in the activity, mRNA levels of CYP2E1 and increased activity and gene expression of GST, thus preventing the accumulation of GA. Also, RES showed the upregulation of few of the DNA repair genes thus preventing mutation accumulation induced by AA and GA. In conclusion RES potential antioxidant property protects HepG2 cells from genotoxicity induced by AA and GA.
Pages: 56-64  |  771 Views  29 Downloads


The Pharma Innovation Journal
How to cite this article:
A Ranjini, HK Manonmani. Resveratrol protects acrylamide / glycidamide induced genotoxicity in hepatic cell line. Pharma Innovation 2019;8(1):56-64.
Important Publications Links
The Pharma Innovation Journal

The Pharma Innovation Journal

Call for book chapter
The Pharma Innovation Journal